Placebo + Psilocybin for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Feb 2018: Trial started, NCT03554174
  2. 13 Jun 2018: Trial registered, NCT03554174

The trials

NCT03554174: Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder

State
Under way
Phase
Phase 1
People
18 planned
Started
27 Feb 2018
Primary completion
8 Jul 2021
Arms
Placebo/Low Dose Psilocybin, Placebo/Medium Dose Psilocybin, Low Dose Psilocybin/Placebo, Medium Dose Psilocybin/Placebo
Results
None posted
  1. 27 Feb 2018: Trial started
  2. 13 Jun 2018: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.